Unbiased genome-wide CRISPR/Cas9 knockout screens have been applied to identify driver genes in different types of cancers, such as lymphoma12, liver tumors13, and breast cancer14, but to our knowledge have not been performed to seek genes that cooperate with oncogenic Kras for transformation. The gene discussed is KRAS; the disease is cancer.